First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks

Por Nicholas, Jacqueline Ann, Racke, Michael Karl, Imitola, Jamie, Boster, Aaron Lee
Publicado em 2014

Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate

Por Nicholas, Jacqueline Ann, Boster, Aaron Lee, Imitola, Jaime, O’Connell, Colleen, Racke, Michael Karl
Publicado em 2014